Ventracor Limited Product Pipeline Analysis

Publication Date	May 2008
Publisher	Global Markets Direct
Product Type	Report
Pages	46
ISBN Number	not applicable
Product Code	GMD04789

Buy this product or for assistance call +44 20 7060 7474

PDF £450.00$749 | €504

FAX Order above formats by FAX

Summary

This report is an insightful source for data, analysis and strategic insights into a Ventracor Limited's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

Details of development stage by sector and equipment type.
Pipeline products grouped by therapy area, development stage and trial phase.
Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
Product updates covering estimated approval dates and estimated launch dates.
Descriptions of novel technologies relating to pipeline products of the company.
Patents and patent applications covered for the product.
News updates on key events relating to the product and its development.

Reason to buy

A single source to fulfill competitor information relating to products in development.
Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

Access clinical trial information to map trial results and plan targeted marketing activities.
Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
Identification of potential investment opportunities.
Build up knowledge base for potential distribution and marketing partners.
Helps avoid patent infringement.
Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content

1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
2 Company Snapshot
- 2.1 Key Information
- 2.2 Company Overview
- 2.3 Financial Performance
- 2.4 Industry Outlook - Cardiovascular Devices
3 Ventracor Limited Pipeline Products
- 3.1 Ventracor Limited Product Pipeline Analysis
  - 3.1.1 Ventracor Limited Pipeline Products By Equipment Type
  - 3.1.2 Ventracor Limited Pipeline Products By Development Stage
  - 3.1.3 Ventracor Limited Pipeline Products By Therapy Area
  - 3.1.4 Ventracor Limited Pipeline Products By Clinical Trials
  - 3.1.5 Ventracor Limited Pipeline Products By News Summary
- 3.2 LVA4
  - 3.2.1 Product Description
  - 3.2.2 Product Status
  - 3.2.3 Product Milestone
- 3.3 VentrAssist (BTT)
  - 3.3.1 Product Description
  - 3.3.2 Product Status
  - 3.3.3 Clinical Trials
  - 3.3.4 Product Milestone
- 3.4 VentrAssist LVAD
  - 3.4.1 Product Description
  - 3.4.2 Product Status
  - 3.4.3 Clinical Trials
  - 3.4.4 Product Milestone
- 3.5 VentrAssist (DT)
  - 3.5.1 Product Description
  - 3.5.2 Product Status
  - 3.5.3 Clinical Trials
  - 3.5.4 Product Milestone
4 Business Description
- 4.1 Business Overview
- 4.2 Major Products and Services
  - 4.2.1 Overview
5 History
6 Competitors
7 Key Employees
8 Key Employee Biographies
9 Company Statement
10 Locations And Subsidiaries
- 10.1 Head Office
- 10.2 Other Locations & Subsidiaries
11 Financial Deals Landscape
- 11.1 IPO
  - 11.1.1 Ventracor Completes Private Placement
12 Recent Developments
- 12.1 Financial Announcements
  - 12.1.1 Feb 22, 2008: Ventracor Declares H1 Fiscal 2008 Results
  - 12.1.2 Sep 20, 2007: Ventracor Declares Fiscal 2007 Results
  - 12.1.3 Feb 13, 2007: Ventracor Declares H1 Fiscal 2007 Results
- 12.2 Other Significant Developments
  - 12.2.1 Apr 03, 2008: Ventracor Announces Board Changes
  - 12.2.2 Mar 13, 2008: Ventracor Names Cardiology Principal Investigator For LVAD
  - 12.2.3 Jul 23, 2007: Ventracor Appoints Non-Executive Director
  - 12.2.4 May 02, 2007: Ventracor Appoints Non-Executive Director
  - 12.2.5 Apr 17, 2007: Ventracor Non-Executive Director To Resign
  - 12.2.6 Aug 22, 2006: Ventracor Appoints CFO
  - 12.2.7 Aug 01, 2006: Ventracor Appoints Executive Director
  - 12.2.8 Jun 28, 2006: Ventracor Appoints New CEO
13 Appendix
- 13.1 Methodology
  - 13.1.1 Coverage
  - 13.1.2 Secondary Research
  - 13.1.3 Primary Research
  - 13.1.4 Expert Panel Validation
- 13.2 Contact Us
- 13.3 About Global Markets Direct
- 13.4 Disclaimer
List of Tables
- Table 1: Ventracor Limited,Key Facts
- Table 2: Ventracor Limited Pipeline Products by Equipment Type
- Table 3: Ventracor Limited Pipeline Products By Development Stage
- Table 4: Ventracor Limited Pipeline Products By Therapy Area
- Table 5: Ventracor Limited Pipeline Products By Clinical Trials
- Table 6: Ventracor Limited Pipeline Products By News Summaries
- Table 7: Ventracor Limited, Key Employees,
- Table 8: Ventracor Limited, Subsidiaries
List of Figures
- Figure 1: Global Markets Direct Methodology